TIAA CREF Investment Management LLC Has $9.04 Million Stake in Allscripts Healthcare Solutions, Inc. (MDRX)

TIAA CREF Investment Management LLC grew its holdings in shares of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) by 7.8% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 708,703 shares of the software maker’s stock after purchasing an additional 51,423 shares during the period. TIAA CREF Investment Management LLC owned approximately 0.39% of Allscripts Healthcare Solutions worth $9,043,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. Wesbanco Bank Inc. lifted its holdings in shares of Allscripts Healthcare Solutions by 131.4% during the 2nd quarter. Wesbanco Bank Inc. now owns 147,587 shares of the software maker’s stock valued at $1,883,000 after purchasing an additional 83,807 shares during the last quarter. Thrivent Financial For Lutherans lifted its holdings in shares of Allscripts Healthcare Solutions by 255.4% during the 1st quarter. Thrivent Financial For Lutherans now owns 111,780 shares of the software maker’s stock valued at $1,418,000 after purchasing an additional 80,330 shares during the last quarter. Dalton Greiner Hartman Maher & Co. purchased a new stake in shares of Allscripts Healthcare Solutions during the 2nd quarter valued at $1,276,000. OppenheimerFunds Inc. lifted its holdings in shares of Allscripts Healthcare Solutions by 9.4% during the 1st quarter. OppenheimerFunds Inc. now owns 31,445 shares of the software maker’s stock valued at $399,000 after purchasing an additional 2,701 shares during the last quarter. Finally, Victory Capital Management Inc. lifted its holdings in shares of Allscripts Healthcare Solutions by 6.8% during the 2nd quarter. Victory Capital Management Inc. now owns 1,627,164 shares of the software maker’s stock valued at $20,763,000 after purchasing an additional 103,395 shares during the last quarter.

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) opened at 14.39 on Monday. The stock’s market cap is $2.60 billion. Allscripts Healthcare Solutions, Inc. has a 52 week low of $9.80 and a 52 week high of $14.45. The company has a 50-day moving average price of $13.56 and a 200-day moving average price of $12.59.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last released its quarterly earnings data on Thursday, August 3rd. The software maker reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.15 by ($0.04). Allscripts Healthcare Solutions had a negative net margin of 11.54% and a positive return on equity of 5.97%. The company had revenue of $426.10 million during the quarter, compared to analyst estimates of $424.94 million. During the same quarter in the prior year, the company earned $0.14 EPS. The business’s revenue was up 10.2% on a year-over-year basis. Equities research analysts anticipate that Allscripts Healthcare Solutions, Inc. will post $0.62 EPS for the current year.

Several analysts have recently commented on the company. Cantor Fitzgerald reiterated a “buy” rating and set a $17.00 price objective (up previously from $15.00) on shares of Allscripts Healthcare Solutions in a report on Monday, August 14th. Citigroup Inc. increased their price objective on Allscripts Healthcare Solutions from $13.00 to $14.00 and gave the company a “neutral” rating in a report on Monday, August 7th. Royal Bank Of Canada assumed coverage on Allscripts Healthcare Solutions in a report on Tuesday, September 19th. They set an “outperform” rating and a $17.00 price objective for the company. BidaskClub upgraded Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a report on Saturday, June 24th. Finally, Leerink Swann lowered Allscripts Healthcare Solutions from an “outperform” rating to a “market perform” rating and decreased their price objective for the company from $15.00 to $13.00 in a report on Monday, June 19th. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and eleven have given a buy rating to the company. Allscripts Healthcare Solutions presently has an average rating of “Buy” and an average target price of $15.19.

In other Allscripts Healthcare Solutions news, President Richard J. Poulton sold 15,000 shares of the company’s stock in a transaction on Friday, September 15th. The shares were sold at an average price of $13.56, for a total value of $203,400.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Brian Farley sold 5,000 shares of the company’s stock in a transaction on Thursday, September 14th. The shares were sold at an average price of $13.52, for a total transaction of $67,600.00. Following the completion of the transaction, the executive vice president now owns 196,607 shares of the company’s stock, valued at approximately $2,658,126.64. The disclosure for this sale can be found here. Insiders sold 35,000 shares of company stock valued at $473,800 in the last 90 days. 0.75% of the stock is currently owned by insiders.

TRADEMARK VIOLATION NOTICE: “TIAA CREF Investment Management LLC Has $9.04 Million Stake in Allscripts Healthcare Solutions, Inc. (MDRX)” was originally reported by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this news story on another site, it was copied illegally and republished in violation of international trademark & copyright laws. The legal version of this news story can be read at https://ledgergazette

Other institutional investors and hedge funds have also modified their holdings of the company. Wesbanco Bank Inc. lifted its holdings in shares of Allscripts Healthcare Solutions by 131.4% during the 2nd quarter. Wesbanco Bank Inc. now owns 147,587 shares of the software maker’s stock valued at $1,883,000 after purchasing an additional 83,807 shares during the last quarter. Thrivent Financial For Lutherans lifted its holdings in shares of Allscripts Healthcare Solutions by 255.4% during the 1st quarter. Thrivent Financial For Lutherans now owns 111,780 shares of the software maker’s stock valued at $1,418,000 after purchasing an additional 80,330 shares during the last quarter. Dalton Greiner Hartman Maher & Co. purchased a new stake in shares of Allscripts Healthcare Solutions during the 2nd quarter valued at $1,276,000. OppenheimerFunds Inc. lifted its holdings in shares of Allscripts Healthcare Solutions by 9.4% during the 1st quarter. OppenheimerFunds Inc. now owns 31,445 shares of the software maker’s stock valued at $399,000 after purchasing an additional 2,701 shares during the last quarter. Finally, Victory Capital Management Inc. lifted its holdings in shares of Allscripts Healthcare Solutions by 6.8% during the 2nd quarter. Victory Capital Management Inc. now owns 1,627,164 shares of the software maker’s stock valued at $20,763,000 after purchasing an additional 103,395 shares during the last quarter.

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) opened at 14.39 on Monday. The stock’s market cap is $2.60 billion. Allscripts Healthcare Solutions, Inc. has a 52 week low of $9.80 and a 52 week high of $14.45. The company has a 50-day moving average price of $13.56 and a 200-day moving average price of $12.59.

Allscripts Healthcare Solutions (NASDAQ:MDRX) last released its quarterly earnings data on Thursday, August 3rd. The software maker reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.15 by ($0.04). Allscripts Healthcare Solutions had a negative net margin of 11.54% and a positive return on equity of 5.97%. The company had revenue of $426.10 million during the quarter, compared to analyst estimates of $424.94 million. During the same quarter in the prior year, the company earned $0.14 EPS. The business’s revenue was up 10.2% on a year-over-year basis. Equities research analysts anticipate that Allscripts Healthcare Solutions, Inc. will post $0.62 EPS for the current year.

Several analysts have recently commented on the company. Cantor Fitzgerald reiterated a “buy” rating and set a $17.00 price objective (up previously from $15.00) on shares of Allscripts Healthcare Solutions in a report on Monday, August 14th. Citigroup Inc. increased their price objective on Allscripts Healthcare Solutions from $13.00 to $14.00 and gave the company a “neutral” rating in a report on Monday, August 7th. Royal Bank Of Canada assumed coverage on Allscripts Healthcare Solutions in a report on Tuesday, September 19th. They set an “outperform” rating and a $17.00 price objective for the company. BidaskClub upgraded Allscripts Healthcare Solutions from a “sell” rating to a “hold” rating in a report on Saturday, June 24th. Finally, Leerink Swann lowered Allscripts Healthcare Solutions from an “outperform” rating to a “market perform” rating and decreased their price objective for the company from $15.00 to $13.00 in a report on Monday, June 19th. One research analyst has rated the stock with a sell rating, eight have issued a hold rating and eleven have given a buy rating to the company. Allscripts Healthcare Solutions presently has an average rating of “Buy” and an average target price of $15.19.

In other Allscripts Healthcare Solutions news, President Richard J. Poulton sold 15,000 shares of the company’s stock in a transaction on Friday, September 15th. The shares were sold at an average price of $13.56, for a total value of $203,400.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Brian Farley sold 5,000 shares of the company’s stock in a transaction on Thursday, September 14th. The shares were sold at an average price of $13.52, for a total transaction of $67,600.00. Following the completion of the transaction, the executive vice president now owns 196,607 shares of the company’s stock, valued at approximately $2,658,126.64. The disclosure for this sale can be found here. Insiders sold 35,000 shares of company stock valued at $473,800 in the last 90 days. 0.75% of the stock is currently owned by insiders.

TRADEMARK VIOLATION NOTICE: “TIAA CREF Investment Management LLC Has $9.04 Million Stake in Allscripts Healthcare Solutions, Inc. (MDRX)” was originally reported by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this news story on another site, it was copied illegally and republished in violation of international trademark & copyright laws. The legal version of this news story can be read at https://ledgergazette.com/2017/10/09/tiaa-cref-investment-management-llc-has-9-04-million-stake-in-allscripts-healthcare-solutions-inc-mdrx.html.

About Allscripts Healthcare Solutions

Allscripts Healthcare Solutions, Inc (Allscripts) delivers information technology (IT) solutions and services to help healthcare organizations. The Company operates through three segments: Clinical and Financial Solutions, Population Health, and Netsmart. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions.

Want to see what other hedge funds are holding MDRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX).

Institutional Ownership by Quarter for Allscripts Healthcare Solutions (NASDAQ:MDRX)

Receive News & Ratings for Allscripts Healthcare Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allscripts Healthcare Solutions Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply